Lijun Gong

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Signaling Pathway

Induced Apoptosis

Top Venues

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)
Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)
Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)
Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)
Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)
Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)
Lijun Gong, Fang Wei, Frank J Gonzalez, Guolin Li
Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore, Md.) (2023)